Cabaletta Bio Inc (CABA) is destined for greater heights as its last quarter sales were 0 K

Zack King

Cabaletta Bio Inc (NASDAQ: CABA) kicked off on Friday, up 46.15% from the previous trading day, before settling in for the closing price of $2.47. Over the past 52 weeks, CABA has traded in a range of $0.99-$5.46.

A company in the Healthcare sector has dropped its sales by -20.35% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 0.58%. With a float of $79.01 million, this company’s outstanding shares have now reached $91.45 million.

In an organization with 161 employees, it is important to assess its efficiency.

Cabaletta Bio Inc (CABA) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cabaletta Bio Inc is 13.61%, while institutional ownership is 70.97%.

Cabaletta Bio Inc (CABA) Performance Highlights and Predictions

In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.62 earnings per share (EPS), lower than consensus estimate (set at -0.61) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 0.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.63% during the next five years compared to -20.35% drop over the previous five years of trading.

Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators

Take a look at Cabaletta Bio Inc’s (CABA) current performance indicators. Last quarter, stock had a quick ratio of 4.78.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.71, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.76 in one year’s time.

Technical Analysis of Cabaletta Bio Inc (CABA)

Let’s dig in a bit further. During the last 5-days, its volume was 9.4 million. That was better than the volume of 2.13 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.63%.

During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 97.51%, which indicates a significant increase from 95.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.23, while its 200-day Moving Average is $1.87. However, in the short run, Cabaletta Bio Inc’s stock first resistance to watch stands at $4.00. Second resistance stands at $4.39. The third major resistance level sits at $5.11. If the price goes on to break the first support level at $2.89, it is likely to go to the next support level at $2.17. Assuming the price breaks the second support level, the third support level stands at $1.78.

Cabaletta Bio Inc (NASDAQ: CABA) Key Stats

The company with the Market Capitalisation of 330.19 million has total of 91,465K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -115,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -45,130 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.